Ursprung des Netzwerks ersten Grades von Eric Rojas
| Einheit | Art der Einheit | Industrie | |
|---|---|---|---|
| Public Company | Biotechnology | 17 |
Unternehmensgrafik - zweiten Grades
Beziehungen zu mehreren Unternehmen
Unternehmensverbindungen über das persönliche Netzwerk von Eric Rojas
| Unternehmen | Sektor | Verknüpfte Personen | Hauptposition |
|---|---|---|---|
| BRISTOL-MYERS SQUIBB COMPANY | Pharmaceuticals: Major | Corporate Officer/Principal | |
| VERTEX PHARMACEUTICALS INCORPORATED | Pharmaceuticals: Major | Director of Finance/CFO Public Communications Contact | |
| DAVITA INC. | Medical/Nursing Services | Director of Finance/CFO | |
| SAREPTA THERAPEUTICS, INC. | Pharmaceuticals: Major | Chief Executive Officer Human Resources Officer General Counsel | |
| THE GOLDMAN SACHS GROUP, INC. | Investment Banks/Brokers | Corporate Officer/Principal | |
| EXELIXIS, INC. | Pharmaceuticals: Major | Director/Board Member | |
Genzyme Corp.
 Genzyme Corp. Medical SpecialtiesHealth Technology Genzyme Corp. engages in development and manufacture of specialty therapeutic, surgical and diagnostic product. It serves in the areas of rare genetic diseases, multiple sclerosis, cardiovascular diseases and endocrinology. The company was founded on June 8, 1981 and is headquartered in Cambridge, MA. | Medical Specialties | Corporate Officer/Principal Human Resources Officer General Counsel | |
| ACORDA THERAPEUTICS, INC. | Pharmaceuticals: Major | Director/Board Member Corporate Officer/Principal | |
Jazz Pharmaceuticals, Inc.
 Jazz Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Jazz Pharmaceuticals, Inc. develops and markets pharmaceutical products. Its medical products include xyrem, erwinaze, vyxeos, and kidrolas. The company was founded by Bruce C. Cozadd in 2003 and is headquartered in Palo Alto, CA. | Pharmaceuticals: Major | Corporate Officer/Principal | |
Biotechnology Innovation Organization
 Biotechnology Innovation Organization Miscellaneous Commercial ServicesCommercial Services Biotechnology Innovation Organization is the world's biotechnology organization, providing advocacy, business development and communications services for more than 1,200 members worldwide. BIO members are involved in the research and development of innovative healthcare, agricultural, industrial and environmental biotechnology technologies. Corporate members range from entrepreneurial companies developing a first product to Fortune 100 multinationals. also represent state and regional biotech associations, service providers to the industry and academic centers. | Miscellaneous Commercial Services | Corporate Officer/Principal | |
| DNIB UNWIND INC | Biotechnology | Director/Board Member | |
| AILERON THERAPEUTICS, INC. | Pharmaceuticals: Major | Chairman Founder | |
| SHIRE | Pharmaceuticals: Major | Chief Tech/Sci/R&D Officer | |
ArmaGen, Inc.
 ArmaGen, Inc. Hospital/Nursing ManagementHealth Services ArmaGen, Inc. engages in operation of a clinical stage biotechnology company focused on developing revolutionary therapies for severe neurological disorders. Its products include AGT-110-Brain-penetrating biologic tumor necrosis factor inhibitor (TNFI) for Alzheimer's disease, AGT-115-Brain-penetrating erythropoietin (EPO) for stroke, AGT-160-Brain penetrating anti-amyloid antibody (AAA) for Alzheimer's disease and AGT-181-Brain-penetrating iduronidase (IDUA) for Mucopolysaccharidosis (MPS) Type I (Hurler's syndrome). The company was founded by William M. Pardridge and Ruben J. Boado in 2003 and is headquartered in San Diego, CA. | Hospital/Nursing Management | Director/Board Member | |
| AVIDITY BIOSCIENCES, INC. | Biotechnology | Director/Board Member Director/Board Member | |
| The Trustees of Columbia University in The City of New York | College/University | Doctorate Degree Undergraduate Degree | |
Harvard University
 Harvard University Other Consumer ServicesConsumer Services Harvard University engages in the provision of teaching and research. It has twelve degree-granting Schools in addition to the Radcliffe Institute for Advanced Study, offering a global education. The university was founded in 1636 and is headquartered in Cambridge, MA. | College/University | Doctorate Degree Doctorate Degree | |
Genzyme General
 Genzyme General Medical SpecialtiesHealth Technology Part of Sanofi, Genzyme General develops and markets specialty therapeutic, surgical, and diagnostic products. The private company is based in Cambridge, MA. | Medical Specialties | Sales & Marketing | |
| University of Cambridge | College/University | Doctorate Degree | |
Novazyme Pharmaceuticals, Inc.
 Novazyme Pharmaceuticals, Inc. Miscellaneous Commercial ServicesCommercial Services Novazyme Pharmaceuticals, Inc. researches and develops methods for modifying recombinantly produced enzymes. It develops a series of novel protein engineering technologies that have been shown in pre-clinical studies to greatly enhance the targeting and uptake of replacement enzymes. Novazyme's technologies also have application for developing advanced monoclonal antibodies and gene therapies. The company is located in Oklahoma City, OK. | Miscellaneous Commercial Services | Corporate Officer/Principal | |
| Boston College | College/University | Undergraduate Degree | |
Cornell University
 Cornell University Other Consumer ServicesConsumer Services Cornell University is an educational institution that offers undergraduate and post graduate programs. It was founded in 1865 and is based in Ithaca, NY. | College/University | Undergraduate Degree | |
| State University of New York at Buffalo | College/University | Masters Business Admin | |
| University of New Hampshire | College/University | Corporate Officer/Principal | |
| California Polytechnic State University (San Luis Obispo) | College/University | Undergraduate Degree | |
Enobia Pharma, Inc.
 Enobia Pharma, Inc. Pharmaceuticals: MajorHealth Technology Enobia Pharma, Inc. develops therapies to treat patients with ultra-rare and life-threatening genetic metabolic bone disorders. Its lead product candidate, asfotase alfa or ENB-0040, is a treatment for hypophosphatasia—a life-threatening disease that can cause skeletal deformity, severe muscle weakness and progressive damage to vital organs. The company was founded in 1997 and is headquartered in Montreal, Canada. | Pharmaceuticals: Major | Corporate Officer/Principal | |
Epilepsy Foundation
 Epilepsy Foundation Miscellaneous Commercial ServicesCommercial Services Epilepsy Foundation provides welfare services. It offers therapies to stop seizures, wellness institute and legal issue services. The company was founded in 1967 and is headquartered in Landover, MD. | Miscellaneous Commercial Services | Corporate Officer/Principal | |
Shire Pharmaceuticals, Inc.
 Shire Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Shire Pharmaceuticals, Inc. manufactures pharmaceutical products. The company offers solutions for attention deficit & hyperactivity disorder, human genetic therapies, gastrointestinal, and renal diseases. The company was founded in 1986 and is headquartered in Wayne, PA | Pharmaceuticals: Major | Corporate Officer/Principal | |
Oligonucleotide Therapeutics Society, Inc.
 Oligonucleotide Therapeutics Society, Inc. Miscellaneous Commercial ServicesCommercial Services Part of Beckman Research Institute of The City of Hope, Oligonucleotide Therapeutics Society, Inc. is a society that envisions a new era of oligonucleotide drugs that would change the landscape of therapeutic modalities. The private company is based in San Diego, CA. Over 100 treatments are in development for common conditions, including cancer and Alzheimer’s disease, as well as rare diseases. The society offers various awards to support the accomplishments of students, postdocs, and young investigators. | Miscellaneous Commercial Services | Director/Board Member Director/Board Member | |
| Harvard Medical School | College/University | Corporate Officer/Principal Corporate Officer/Principal | |
| RAPTOR PHARMACEUTICAL CORP | Pharmaceuticals: Major | Chief Executive Officer | |
Raptor Pharmaceuticals, Inc.
 Raptor Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Raptor Pharmaceuticals, Inc. operates as a biopharmaceutical company which develops and markets life-altering therapeutics. The company is headquartered in Novato, CA. | Pharmaceuticals: Major | Chief Executive Officer | |
| Epilepsy Therapy Project | Director/Board Member | ||
| LOXO ONCOLOGY INC | Pharmaceuticals: Major | Director of Finance/CFO | |
| AUDENTES THERAPEUTICS, INC. | Biotechnology | Director/Board Member | |
| AXCA HEALPAR | Biotechnology | Corporate Officer/Principal | |
| Stanford Graduate School of Business | College/University | Masters Business Admin | |
| TCR2 THERAPEUTICS INC. | Pharmaceuticals: Major | Chief Executive Officer | |
| BLACK DIAMOND THERAPEUTICS, INC. | Biotechnology | Director/Board Member | |
Nuredis, Inc.
 Nuredis, Inc. BiotechnologyHealth Technology Nuredis, Inc. develops treatments for neurodegenerative and neuromuscular diseases. The private company is based in Menlo Park, CA. The company was founded by Stanley N. Cohen. | Biotechnology | Chief Executive Officer | |
| AKOUOS | Biotechnology | Chairman | |
Treeline Biosciences, Inc.
 Treeline Biosciences, Inc. BiotechnologyHealth Technology Treeline Biosciences, Inc. develops transformative precision medicines for patients with cancer. The company is based in Stamford, CT. The company was founded by Joshua H. Bilenker. Joshua H. Bilenker has been the CEO since incorporation. | Biotechnology | Corporate Officer/Principal | |
Nuvig Therapeutics, Inc.
 Nuvig Therapeutics, Inc. BiotechnologyHealth Technology Nuvig Therapeutics, Inc. is a company that is focused on developing innovative therapies for patients with chronic autoimmune diseases. The company is based in Redwood City, CA. The company's goal is to induce natural mechanisms that restore immune homeostasis and rebalance immune function following inflammation. Nuvig Therapeutics was founded by Greg Coffey, Jeffrey V. Ravetch, Sheldon L. Koenig, Pamela B. Conley, Joanne M. Quan. Julie Anne Smith has been the CEO of the company since 2023. | Biotechnology | Chief Executive Officer | |
GHO Capital Partners LLP
 GHO Capital Partners LLP Investment ManagersFinance GHO Capital Partners LLP (GHO Capital Partners) is a private equity firm founded in 2014 by Mireille G. Gillings, Dennis B. Gillings, Alan Browning MacKay, Michael Irvine Mortimer and Andrea Ponti. The firm is headquartered in London, United Kingdom. | Investment Managers | Private Equity Investor | |
| ADAPTIMMUNE THERAPEUTICS PLC | Biotechnology | Director/Board Member |
Statistik
International
| Vereinigte Staaten | 45 |
| Vereinigtes Königreich | 5 |
| Irland | 2 |
| Kanada | 2 |
Sektoral
| Health Technology | 32 |
| Consumer Services | 11 |
| Commercial Services | 5 |
| Health Services | 3 |
| Finance | 3 |
Operativ
| Director/Board Member | 85 |
| Corporate Officer/Principal | 53 |
| Independent Dir/Board Member | 22 |
| Chairman | 16 |
| Undergraduate Degree | 16 |
Am stärksten vernetzte Beziehungen
| Insiders | |
|---|---|
| Seth Harrison | 43 |
| Ian Smith | 24 |
| Garry Menzel | 19 |
| Julie Smith | 15 |
| Arthur Tzianabos | 15 |
| Edward Kaye | 13 |
| Shamim Ruff | 12 |
| Arthur Levin | 10 |
| Barry Ticho | 9 |
| Adrian Krainer | 9 |
| Joan Wood | 8 |
| Jennifer Burstein | 6 |
| Jonathan Allan | 6 |
| Huw Nash | 5 |
| Isabel Aznarez | 4 |
- Börse
- Insiders
- Eric Rojas
- Unternehmensverbindungen
